首頁 > 市場調查報告書 > 製藥

再生醫學細胞療法

市場調查報告書

商品編碼

1619047

細胞治療技術市場規模、佔有率、成長分析、按類型、按工藝、按細胞類型、按最終用戶、按地區 - 行業預測，2024-2031 年

Cell Therapy Technologies Market Size, Share, Growth Analysis, By Type, By Process, By Cell Type, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年12月18日 | 出版商:

SkyQuest | 英文 201 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年細胞治療技術的全球市場規模為39億美元，從2023年的44.3億美元成長到2031年的121.9億美元，並且預計在預測期內（2024-2031年）將持續成長。為13.50%。

在臨床研究資金增加和實用生產指南建立的推動下，細胞治療市場正在經歷顯著成長。高品質的研究正在推動治療細胞開發的進步，從而導致市場佔有率的顯著成長。臨床試驗的增加主要得到私人和政府資助機構的支持，歐洲計劃經常得到歐盟津貼的支持。例如，Achilles Therapeutics 於 2022 年 7 月獲得了 420 萬美元的 Horizon Europe 獎項，以進一步推進個人化醫療。此外，細胞治療技術的進步，例如 CRISPR/Cas9 等基因編輯技術和自動化製造，正在提高細胞治療的擴充性和品質。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 西班牙
- 法國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東/非洲
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭資訊

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市場趨勢
公司市場佔有率分析（2023）
主要企業簡介
- 公司簡介
- 產品系列分析
- 按細分市場分類的佔有率分析
- 收益與前一年同期比較（2021-2023）

主要企業簡介

Thermo Fisher Scientific, Inc.
Merck KGaA
Danaher Corporation
Lonza Group
Sartorius AG
Terumo BCT, Inc.
Becton Dickinson and Company
Fresenius SE & Co. KGaA
Avantor, Inc.
Bio-Techne
Corning Incorporated
Fujifilm Irvine Scientific
MaxCyte, Inc.
Werum IT Solutions
RoosterBio, Inc.
TrakCel
L7 Informatics, Inc.
Miltenyi Biotec BV & Co. KG
STEMCELL Technologies
GPI Iberia（formerly Hemasoft）

結論和建議

簡介目錄

Product Code: SQMIG35A2873

Global Cell Therapy Technologies Market size was valued at USD 3.9 billion in 2022 and is poised to grow from USD 4.43 billion in 2023 to USD 12.19 billion by 2031, growing at a CAGR of 13.50% during the forecast period (2024-2031).

The cell therapy market is experiencing significant growth fueled by increased funding for clinical research and the establishment of practical guidelines for production. Robust quality research is driving the advancement of therapeutic cell development, resulting in a notable market share expansion. The rise in clinical trials is largely supported by both private and government funding agencies, with European projects frequently backed by EU grants; for instance, Achilles Therapeutics secured a $4.2 million Horizon Europe award in July 2022 to further personalized medicine. Additionally, advancements in cell therapy techniques, including gene editing technologies like CRISPR/Cas9 and automation in manufacturing, are enhancing the scalability and quality of cell therapies, while regulatory approvals remain a decisive factor in market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Therapy Technologies market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Therapy Technologies Market Segmental Analysis

Global Cell Therapy Technologies Market is segmented by Type, Process, Cell Type, End User, and region. Based on Type, the market is segmented into Media, sera, and reagents, Cell engineering products, Cell culture vessels, Cell therapy equipment, Systems & software, and Other products. Based on Process, the market is segmented into Cell Processing, Cell preservation, distribution, and handling, and Process monitoring & quality control. Based on Cell Type, the market is segmented into T cells, Stem cells, and Other cells. Based on End User, the market is segmented into Biopharmaceutical & biotechnology companies, CROs & CMOs, and Research institutes & cell banks. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell Therapy Technologies Market

One of the key drivers fueling the expansion of the global cell therapy technologies market is the continuous emergence of innovative therapies. This growth is largely attributable to the frequent introduction of advanced technologies aimed at facilitating state-of-the-art treatments. Notably, the deployment of proprietary cell lines is recognized as an effective method for achieving a substantial target population for specific products. A prime example of this is Immunicum's utilization of Chimeric Antigen Receptor T cell (CAR-T) expansion, along with dendritic cell neoantigen presentation techniques and T-cell priming strategies, all of which significantly enhance the development of their immuno-oncology portfolio.

Restraints in the Global Cell Therapy Technologies Market

The Global Cell Therapy Technologies market faces significant challenges due to a shortage of skilled labor. Despite notable technological progress and innovations in recent years, there remains a dearth of qualified personnel capable of operating sophisticated instruments like flow cytometers and spectrophotometers. These advanced tools produce substantial volumes of data, necessitating a high level of expertise for effective analysis and interpretation. This gap in skilled workforce not only hampers operational efficiency but also poses a barrier to the overall growth and advancement of the cell therapy sector, potentially limiting its ability to leverage technological advancements fully.

Market Trends of the Global Cell Therapy Technologies Market

The Global Cell Therapy Technologies market is experiencing significant growth, driven by the increasing demand for advanced analytical tools that enhance quality control and improvement. Innovative diagnostics, imaging technologies, and robust data analytics facilitate the streamlined monitoring and characterization of cellular materials, ensuring enhanced efficacy and safety profiles. The development of new biomaterials and scaffolds for improved cell delivery and engraftment is garnering heightened interest, offering benefits like better biocompatibility and controlled release kinetics. Moreover, intensified collaboration between research institutions is fostering innovation, aiding the rapid translation of cell therapy technologies from laboratory research to clinical application, positioning this sector for continued expansion.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Patent Analysis
Case Studies

Global Cell Therapy Technologies Market Size by Product & CAGR (2024-2031)

Market Overview
Media, sera, and reagents
Cell engineering products
Cell culture vessels
Cell therapy equipment
- Cell Processing equipment
- Single-use equipment
- Other equipment
Systems & software
Other products

Global Cell Therapy Technologies Market Size by Process & CAGR (2024-2031)

Market Overview
Cell Processing
Cell preservation, distribution, and handling
Process monitoring & quality control

Global Cell Therapy Technologies Market Size by Cell Type & CAGR (2024-2031)

Market Overview
T cells
Stem cells
Other cells

Global Cell Therapy Technologies Market Size by End User & CAGR (2024-2031)

Market Overview
Biopharmaceutical & biotechnology companies
CROs & CMOs
Research institutes & cell banks

Global Cell Therapy Technologies Market Size & CAGR (2024-2031)

North America (Product, Process, Cell Type, End User)
- US
- Canada
Europe (Product, Process, Cell Type, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific (Product, Process, Cell Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America (Product, Process, Cell Type, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Process, Cell Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza Group
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo BCT, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton Dickinson and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius SE & Co. KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avantor, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Irvine Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MaxCyte, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Werum IT Solutions
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RoosterBio, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TrakCel
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
L7 Informatics, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec B.V. & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STEMCELL Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GPI Iberia (formerly Hemasoft)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments